FDA Inspection 1039611 — Krajsova, Ivana
The FDA completed an inspection of Krajsova, Ivana on Nov 2, 2017 in Prague 28. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 2, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Prague 28 (Czech Republic)
Additional Details
Clinical Investigator (CI)